Anish Bhatnagar's most recent trade in Soleno Therapeutics Inc was a trade of 281,053 Employee stock option (right to buy) done . Disclosure was reported to the exchange on March 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2025 | 281,053 | 200,753 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.25 per share. | 27 Mar 2025 | 281,053 | 1,100,885 (2%) | 0% | 5.2 | 1,475,528 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 66.33 per share. | 27 Mar 2025 | 209,689 | 784,725 (1%) | 0% | 66.3 | 13,908,797 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 69.30 per share. | 27 Mar 2025 | 199,226 | 577,076 (1%) | 0% | 69.3 | 13,805,904 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 65.81 per share. | 27 Mar 2025 | 106,471 | 994,414 (2%) | 0% | 65.8 | 7,007,059 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2025 | 105,000 | 35,000 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.60 per share. | 27 Mar 2025 | 105,000 | 725,348 (1%) | 0% | 33.6 | 3,528,000 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2025 | 62,291 | 52,709 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.41 per share. | 27 Mar 2025 | 62,291 | 819,832 (1%) | 0% | 2.4 | 150,121 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 68.79 per share. | 27 Mar 2025 | 55,234 | 617,861 (1%) | 0% | 68.8 | 3,799,442 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 67.70 per share. | 27 Mar 2025 | 41,989 | 673,095 (1%) | 0% | 67.7 | 2,842,685 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2025 | 32,193 | 8,473 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 27 Mar 2025 | 32,193 | 757,541 (1%) | 0% | 5.1 | 164,184 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 69.84 per share. | 27 Mar 2025 | 31,980 | 585,881 (1%) | 0% | 69.8 | 2,233,390 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2025 | 26,606 | 60 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.00 per share. | 27 Mar 2025 | 26,606 | 603,682 (1%) | 0% | 24 | 638,544 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 66.79 per share. | 27 Mar 2025 | 23,095 | 715,084 (1%) | 0% | 66.8 | 1,542,552 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2025 | 16,666 | 0 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.05 per share. | 27 Mar 2025 | 16,666 | 620,348 (1%) | 0% | 25.0 | 417,483 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 65.97 per share. | 27 Mar 2025 | 14,183 | 738,179 (1%) | 0% | 66.0 | 935,640 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 67.37 per share. | 27 Mar 2025 | 8,423 | 776,302 (1%) | 0% | 67.4 | 567,458 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 71.74 per share. | 27 Mar 2025 | 4,782 | 577,808 (1%) | 0% | 71.7 | 343,076 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 70.73 per share. | 27 Mar 2025 | 3,291 | 582,590 (1%) | 0% | 70.7 | 232,786 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 72.64 per share. | 27 Mar 2025 | 732 | 577,076 (1%) | 0% | 72.6 | 53,172 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 115,600 | 115,600 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 53,900 | 752,362 (1%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 46.18 per share. | 02 Jan 2025 | 10,154 | 698,462 (1%) | 0% | 46.2 | 468,875 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 45.37 per share. | 02 Jan 2025 | 10,077 | 709,476 (1%) | 0% | 45.4 | 457,149 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 45.92 per share. | 02 Jan 2025 | 860 | 708,616 (1%) | 0% | 45.9 | 39,491 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 49.34 per share. | 01 Oct 2024 | 19,413 | 721,773 (1%) | 0% | 49.3 | 957,756 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 50.25 per share. | 01 Oct 2024 | 2,220 | 719,553 (1%) | 0% | 50.2 | 111,550 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 47.16 per share. | 28 Aug 2024 | 47,551 | 752,026 (1%) | 0% | 47.2 | 2,242,486 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 47.19 per share. | 28 Aug 2024 | 30,262 | 825,928 (1%) | 0% | 47.2 | 1,428,142 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 48.03 per share. | 28 Aug 2024 | 26,351 | 799,577 (1%) | 0% | 48.0 | 1,265,570 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 47.83 per share. | 28 Aug 2024 | 10,840 | 741,186 (1%) | 0% | 47.8 | 518,509 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 45.89 per share. | 05 Aug 2024 | 39,405 | 856,190 (1%) | 0% | 45.9 | 1,808,295 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 45.48 per share. | 05 Aug 2024 | 32,789 | 950,745 (2%) | 0% | 45.5 | 1,491,136 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 46.14 per share. | 05 Aug 2024 | 25,424 | 925,321 (2%) | 0% | 46.1 | 1,173,163 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 45.25 per share. | 05 Aug 2024 | 22,937 | 895,595 (2%) | 0% | 45.2 | 1,037,833 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 43.64 per share. | 05 Aug 2024 | 6,789 | 918,532 (2%) | 0% | 43.6 | 296,270 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 850,000 | 983,534 (2%) | 1% | 0 | Common Stock | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 41.63 per share. | 01 Jul 2024 | 15,058 | 133,534 (0%) | 0% | 41.6 | 626,795 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 41.22 per share. | 01 Jul 2024 | 4,198 | 148,592 (0%) | 0% | 41.2 | 173,049 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 41.12 per share. | 01 Apr 2024 | 11,383 | 160,387 (0%) | 0% | 41.1 | 468,100 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 41.67 per share. | 01 Apr 2024 | 7,597 | 152,790 (0%) | 0% | 41.7 | 316,545 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 48.30 per share. | 25 Jan 2024 | 2,527 | 171,770 (0%) | 0% | 48.3 | 122,054 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 150,000 | 174,297 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 100,000 | 100,000 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | Bhatnagar Anish | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 35.26 per share. | 11 Dec 2023 | 51,205 | 66,500 (0%) | 0% | 35.3 | 1,805,478 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 36.00 per share. | 11 Dec 2023 | 35,272 | 31,228 (0%) | 0% | 36.0 | 1,269,729 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 37.01 per share. | 11 Dec 2023 | 6,931 | 24,297 (0%) | 0% | 37.0 | 256,495 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.65 per share. | 30 Nov 2023 | 27,716 | 108,062 (0%) | 0% | 28.7 | 794,116 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.50 per share. | 20 Oct 2023 | 4,000 | 193,283 (0%) | 0% | 4.5 | 18,000 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2023 | 4,000 | 0 | - | - | Warrants (right to buy) | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 20 Oct 2023 | 3,500 | 198,926 (0%) | 0% | 2.5 | 8,750 | Common Stock |
| Soleno Therapeutics Inc | Bhatnagar Anish | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2023 | 3,500 | 0 | - | - | Warrants (right to buy) | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2023 | 2,143 | 0 | - | - | Warrants (right to buy) | |
| Soleno Therapeutics Inc | Bhatnagar Anish | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.75 per share. | 20 Oct 2023 | 2,143 | 195,426 (0%) | 0% | 1.7 | 3,750 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 481,806 | 481,806 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 160,602 | 189,283 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2023 | 3,500 | 3,500 | - | - | Warrants (right to buy) | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2023 | 2,143 | 2,143 | - | - | Warrants (right to buy) | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 115,000 | 115,000 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2022 | 1,100,000 | 1,100,000 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2022 | 60,000 | 60,000 | - | - | Warrant (right to buy) | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2022 | 60,000 | 430,227 (0%) | 0% | - | Common Stock | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 610,000 | 610,000 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | Anish Bhatnagar | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.37 per share. | 21 Jan 2022 | 39,033 | 370,227 (0%) | 0% | 0.4 | 14,559 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.11 per share. | 23 Jan 2021 | 36,318 | 409,260 (0%) | 0% | 2.1 | 76,631 | Common Stock |
| Soleno Therapeutics Inc | Anish Bhatnagar | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2021 | 2,100,000 | 4,097,098 | - | - | Employee stock option (right to buy) |